| S1082 |
Vismodegib (GDC-0449)
|
Vismodegib (GDC-0449) is a potent, novel and specific hedgehog inhibitor with IC50 of 3 nM and also inhibits P-gp with IC50 of 3.0 μM in a cell-free assay.
|
-
Nat Commun, 2025, 16(1):5137
-
Nat Commun, 2025, 16(1):1092
-
Nat Commun, 2025, 16(1):1267
|
|
| S8075 |
GANT 61 (NSC 136476)
|
GANT61 (NSC 136476) is an inhibitor for GLI1 as well as GLI2-induced transcription, inhibits hedgehog with IC50 of 5 μM in GLI1 expressing HEK293T cell, displays selectivity over other pathways, such as TNF and glucocorticoid receptor gene transactivation. GANT61 induces apoptosis and activates protective autophagy in LX-2 cells.
|
-
Nat Commun, 2025, 16(1):1267
-
Theranostics, 2025, 15(18):9819-9837
-
J Exp Clin Cancer Res, 2025, 44(1):22
|
|
| S2476 |
Itraconazole
|
Itraconazole is a relatively potent inhibitor of CYP3A4 with IC50 of 6.1 nM, used as a triazole antifungal agent. This compound is a potent antagonist of the Hedgehog (Hh) signaling pathway. It also suppresses the growth of glioblastoma through induction of autophagy.
|
-
Cell Rep Med, 2025, S2666-3791(25)00272-1
-
Infect Drug Resist, 2025, 18:783-789
-
Toxicol Appl Pharmacol, 2025, 502:117404
|
|
| S8249 |
HPI-4 (Ciliobrevin A)
|
HPI-4 (Ciliobrevin A, Hedgehog Pathway Inhibitor 4) is a hedgehog (Hh) pathway antagonist. It blocks Sonic hedgehog (Shh)-induced Hh pathway activation (IC50 = 7 μM) downstream of Smo.
|
-
Commun Biol, 2025, 8(1):607
-
International Journal of Molecular Sciences, 2025, 2138
-
Int J Mol Sci, 2025, 26(5)2138
|
|
| S2157 |
Taladegib (LY2940680)
|
Taladegib (LY2940680) binds to the Smoothened (Smo) receptor and potently inhibits Hedgehog (Hh) signaling in Phase 1/2.
|
-
Sci Rep, 2022, 12(1):7
-
Carcinogenesis, 2020, 41(7):993-1004
-
Front Pharmacol, 2019, 10:89
|
|
| S7160 |
Glasdegib
|
Glasdegib is a potent, and orally bioavailable Smoothened (Smo) inhibitor with IC50 of 5 nM. Phase 2.
|
-
J Extracell Vesicles, 2025, 14(9):e70163
-
iScience, 2024, 27(10):110862
-
Leukemia, 2023, 37(8):1649-1659
|
|
| S9743 |
Ciliobrevin D
|
Ciliobrevin D (compound 5) is a cell-permeable, reversible and specific antagonist of AAA+ (ATPases associated with diverse cellular activities) ATPase motor cytoplasmic dynein. This compound perturbs primary cilia formation and blocks Hedgehog (Hh) signaling.
|
-
Cell Prolif, 2025, e13819.
-
ACS Chem Biol, 2024, 19(8):1733-1742
-
Mol Cell, 2022, S1097-2765(22)00327-6
|
|
| S4747 |
Jervine
|
Jervine (11-Ketocyclopamine) is a Hedgehog signaling (IC50=500-700 nM) inhibitor that inhibits the sonic hedgehog (shh) pathway by interacting with smoothened.
|
-
FASEB J, 2025, 39(20):e71187
-
Sci Rep, 2022, 12(1):7
-
Neurochem Int, 2021, 146:105042
|
|
| S8200 |
MK-4101
|
MK-4101, a potent inhibitor of the Hedgehog pathway, shows anti-tumor activity through the inhibition of proliferation and induction of extensive apoptosis in tumor cells.
|
-
Sci Rep, 2022, 12(1):7
|
|
| S6565 |
JK184
|
JK184 inhibits Gli in the Hedgehog (Hh) pathway with IC50 of 30 nM in mammalian cells.
|
-
Cell Res, 2020, 10.1038/s41422-020-00426-0
|
|
| E0782 |
MRT 10
|
MRT-10 inhibits ShhN signaling in Shh-light2 cells in a dose-dependent manner with IC50 of 0.64 μM, showing the capacity to abrogate the constitutive activity of Smo.
|
|
|